ClinicalTrials.Veeva

Menu

Study of 2 Modalities of Dialysis and Nutrition on the Nutritional Status of Malnourished Chronic Renal Disease Patients

G

GCS Ramsay Santé pour l'Enseignement et la Recherche

Status

Completed

Conditions

Renal Insufficiency

Treatments

Dietary Supplement: intradialytic parenteral nutrition
Dietary Supplement: oral nutritional supplementation

Study type

Interventional

Funder types

Other

Identifiers

NCT04445558
2020-A01267-32

Details and patient eligibility

About

Describe the impact of dialysis by high permeability and adsorbent membrane (PEPA®) associated with oral nutritional supplementation on the nutritional status of malnourished chronic end-stage renal disease patients dependent on intradialytic parenteral nutrition.

Full description

The study proposes to compare the nutritional state after 6 months of dialysis with standard membrane associated with intradialytic parenteral nutrition (retrospective phase) with the nutritional state after 6 months of dialysis with high permeability membrane associated with oral nutritional supplementation (prospective phase).

Enrollment

11 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with renal failure, on hemodialysis for at least 12 months;
  • Hemodialysis patient in 3 weekly sessions on a device with a standard permeability membrane (polysulfone, polyethersulfone or polyartylethersulfone type);
  • Malnourished patient, on intradialytic parenteral nutrition for at least 6 months;
  • Patient who may benefit, according to the doctor, from a change in dialysis and nutrition strategy:
  • Patient who signed an informed consent form to participate in the study

Exclusion criteria

  • Known allergy to PEPA® ;
  • Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
  • Patient with a chronic infection in progress;
  • Patient with life expectancy <6 months according to the investigator;
  • Inability to understand information related to the study (linguistic, psychological, cognitive reason, etc.);
  • Pregnant woman or likely to be (of childbearing age, without effective contraception) or breastfeeding;
  • Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
  • Patient not benefiting from a social security scheme.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

11 participants in 2 patient groups

Membrane PEPA®
Experimental group
Description:
Patient will use the membrane PEPA® for the dialysis
Treatment:
Dietary Supplement: oral nutritional supplementation
Standard membrane of dialysis
Active Comparator group
Description:
Patient will use a standard membrane for the dialysis
Treatment:
Dietary Supplement: intradialytic parenteral nutrition

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems